Page 69 - e-CPG-SLE-8_5_24
P. 69

Management of Systemic Lupus Erythematosus

           110. Levy  RA,  Vilela  VS,  Cataldo  MJ,  et  al.  Hydroxychloroquine  (HCQ)  in  lupus
               pregnancy: double-blind and placebo-controlled study. Lupus. 2001;10(6):401-
               404.
           111. Clowse MEB, Eudy AM, Balevic S, et al. Hydroxychloroquine in the pregnancies
               of women with lupus: a meta-analysis of individual participant data. Lupus Sci
               Med. 2022;9(1):e000651.
           112. Do SC, Rizk NM, Druzin ML, et al. Does Hydroxychloroquine Protect against
               Preeclampsia  and  Preterm  Delivery  in  Systemic  Lupus  Erythematosus
               Pregnancies? Am J Perinatol. 2020;37(9):873-880.
           113. Seo  MR,  Chae  J,  Kim  YM,  et  al.  Hydroxychloroquine  treatment  during
               pregnancy in lupus patients is associated with lower risk of preeclampsia. Lupus.
               2019;28(6):722-730.
           114. Thaha M, Alsagaff MY, Dwi Suryantoro S, et al. High-dose vs low-dose steroid
               in pregnancy patients with systemic lupus erythematosus and lupus nephritis: A
               systematic review and meta-analysis. F1000Research. 2022;11:1-16.
           115. Tani  C,  Zucchi  D,  Haase  I,  et  al.  Impact  of  low-dose  acetylsalicylic  acid  on
               pregnancy outcome in systemic lupus erythematosus: results from a multicentre
               study. Lupus Sci Med. 2022;9(1):e000714.
           116. Klein-Gittelman M, Lane JC, Lane J. Systemic Lupus Erythematosus. In: Petty
               R, Laxer R, Lindsley C, Wedderburn L, Cassidy J, editors. Textbook of pediatric
               rheumatology. 7th ed. Philadelphia, PA: Elsevier; 2016.
           117. Foster  HE,  Minden  K,  Clemente  D,  et  al.  EULAR/PReS  standards  and
               recommendations for the transitional care of young people with juvenile-onset
               rheumatic diseases. Ann Rheum Dis. 2017;76(4):639-646.
           118. Felsenstein S, Reiff AO, Ramanathan A. Transition of Care and Health-Related
               Outcomes in Pediatric-Onset Systemic Lupus Erythematosus. Arthritis Care Res
               (Hoboken). 2015;67(11):1521-1528.
           119. Son  MB,  Sergeyenko  Y,  Guan  H,  et  al.  Disease  activity  and  transition
               outcomes  in  a  childhood-onset  systemic  lupus  erythematosus  cohort.  Lupus.
               2016;25(13):1431-1439.
           120. Clemente D, Leon L, Foster H, et al. Systematic review and critical appraisal
               of  transitional  care  programmes  in  rheumatology.  Semin  Arthritis  Rheum.
               2016;46(3):372-379.
           121. Furer V, Rondaan C, Heijstek MW, et al. 2019 update of EULAR recommendations
               for  vaccination  in  adult  patients  with  autoimmune  inflammatory  rheumatic
               diseases. Ann Rheum Dis. 2020;79(1):39-52.
           122. Adawi  M,  Bragazzi  NL,  McGonagle  D,  et  al.  Immunogenicity,  safety  and
               tolerability of anti-pneumococcal vaccination in systemic lupus erythematosus
               patients: An evidence-informed and PRISMA compliant systematic review and
               meta-analysis. Autoimmun Rev. 2019;18(1):73-92.
           123. Liao Z, Tang H, Xu X, et al. Immunogenicity and Safety of Influenza Vaccination
               in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A
               Meta-Analysis. PLoS One. 2016;11(2):e0147856.
           124. Jena A, Mishra S, Deepak P, et al. Response to SARS-CoV-2 vaccination in
               immune mediated inflammatory diseases: Systematic review and meta-analysis.
               Autoimmun Rev. 2022;21(1):102927.
           125. Larsen  ES,  Nilsson  AC,  Möller  S,  et  al.  Immunogenicity  and  risk  of  disease
               flare  after  a  three-dose  regimen  with  SARS-CoV-2  vaccination  in  patients
               with systemic lupus erythematosus: results from the prospective cohort study
               COVAC-SLE. Clin Exp Rheumatol. 2023;41(3):676-684.
           126. Mok  CC,  Ho  LY,  To  CH.  Long-term  immunogenicity  of  a  quadrivalent
               human  papillomavirus  vaccine  in  systemic  lupus  erythematosus.  Vaccine.
               2018;36(23):3301-3307.

                                      52
   64   65   66   67   68   69   70   71   72   73   74